Business Segments and Geographic Information

12 Months Ended

Sep. 24, 2016

Segment Reporting [Abstract]

Business Segments and Geographic Information

Business Segments and Geographic Information

The Company reports segment information in accordance with ASC 280, Segment Reporting. Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company’s chief operating decision maker is its chief executive officer, and the Company’s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset impairment charges, restructuring and divestiture charges, litigation charges, and other one-time or unusual items.

Identifiable assets for the four principal reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2016, 2015, and 2014 was as follows:

	Years ended
	September 24, 2016		September 26, 2015		September 27, 2014
Total revenues:
Diagnostics	$	1,236.9	$	1,211.8	$	1,186.8
Breast Health	1,112.8		1,063.4		944.7
GYN Surgical	393.1		335.8		307.9
Skeletal Health	89.9		94.0		91.3
	$	2,832.7	$	2,705.0	$	2,530.7
Operating income:
Diagnostics	$	126.0	$	109.5	$	48.7
Breast Health	350.5		296.3		187.6
GYN Surgical	69.1		38.6		30.3
Skeletal Health	3.0		10.7		13.1
	$	548.6	$	455.1	$	279.7
Depreciation and amortization:
Diagnostics	$	341.8	$	358.7	$	376.0
Breast Health	22.6		28.6		41.7
GYN Surgical	99.9		102.7		104.6
Skeletal Health	1.1		1.4		0.9
	$	465.4	$	491.4	$	523.2
Capital expenditures:
Diagnostics	$	53.5	$	55.6	$	52.2
Breast Health	10.6		12.8		10.0
GYN Surgical	17.7		9.5		8.0
Skeletal Health	0.4		0.4		0.4
Corporate	12.3		11.1		9.6
	$	94.5	$	89.4	$	80.2

	September 24, 2016		September 26, 2015		September 27, 2014
Identifiable assets:
Diagnostics	$	3,771.9	$	4,055.8	$	4,383.5
Breast Health	809.1		815.4		859.8
GYN Surgical	1,570.7		1,658.1		1,748.2
Skeletal Health	30.9		25.3		26.1
Corporate	1,134.4		1,087.9		1,351.1
	$	7,317.0	$	7,642.5	$	8,368.7

The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.

Revenues by geography as a percentage of total revenues were as follows:

	Years ended
	September 24, 2016		September 26, 2015		September 27, 2014
United States	78.9	%	76.0	%	75.1	%
Europe	10.2	%	11.8	%	13.3	%
Asia-Pacific	7.6	%	8.5	%	7.7	%
All others	3.3	%	3.7	%	3.9	%
	100.0	%	100.0	%	100.0	%

The Company’s property, plant and equipment, net are geographically located as follows:

	September 24, 2016		September 26, 2015		September 27, 2014
United States	$	370.7	$	369.1	$	366.8
Costa Rica	28.1		27.7		27.9
Europe	49.2		50.8		56.0
All other countries	12.2		9.5		11.2
	$	460.2	$	457.1	$	461.9